Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt Zatloukal

Showing results (1-10 of 202) with videos related to

Pageof 21
Sort By:
Hepatology (Baltimore, Md.)|December 2, 2017
Bringing the cell nucleus in the focus of NAFLDKurt Zatloukal
Hepatology (Baltimore, Md.)|May 31, 2012
Insights into molecular mechanisms contributing to individual susceptibility to steatohepatitis: lessons learned from mouse modelsKurt Zatloukal
Biopreservation and Biobanking|May 23, 2014
What are the next steps to overcoming roadblocks to transnational biobank collaboration?Kurt Zatloukal, Jim Vaught
Biomarkers in Medicine|December 8, 2010
Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicineKurt Zatloukal, Pierre Hainaut
Briefings in Functional Genomics & Proteomics|October 6, 2007
Biobanks: transnational, European and global networksMartin Asslaber, Kurt Zatloukal
New Biotechnology|December 15, 2024
Is human oversight to AI systems still possible?Andreas Holzinger, Kurt Zatloukal, Heimo Müller
Virchows Archiv : an International Journal of Pathology|January 30, 2024
Mallory-Denk bodies and hepatocellular senescence: a causal relationship?Helmut Denk, Peter M Abuja, Kurt Zatloukal
EMBO Reports|February 28, 2009
miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasisChristoph A Gebeshuber, Kurt Zatloukal, Javier Martinez
Clinical Chemistry|October 15, 2025
Regulatory Fragmentation in Europe and Its Risks for Patient Access and Safety: Subcontracting Work Flow Steps of In-House Diagnostic ProceduresRaymond Nistor-Gallo, Kurt Zatloukal, Karin Schwenoha
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 11, 2018
Animal models of NAFLD from the pathologist's point of viewHelmut Denk, Peter M Abuja, Kurt Zatloukal
Pageof 21

Showing results (1-10 of 202) with videos related to

Sort By:
Pageof 21
Hepatology (Baltimore, Md.)|December 2, 2017
Bringing the cell nucleus in the focus of NAFLDKurt Zatloukal
Hepatology (Baltimore, Md.)|May 31, 2012
Insights into molecular mechanisms contributing to individual susceptibility to steatohepatitis: lessons learned from mouse modelsKurt Zatloukal
Biopreservation and Biobanking|May 23, 2014
What are the next steps to overcoming roadblocks to transnational biobank collaboration?Kurt Zatloukal, Jim Vaught
Biomarkers in Medicine|December 8, 2010
Human tissue biobanks as instruments for drug discovery and development: impact on personalized medicineKurt Zatloukal, Pierre Hainaut
Briefings in Functional Genomics & Proteomics|October 6, 2007
Biobanks: transnational, European and global networksMartin Asslaber, Kurt Zatloukal
New Biotechnology|December 15, 2024
Is human oversight to AI systems still possible?Andreas Holzinger, Kurt Zatloukal, Heimo Müller
Virchows Archiv : an International Journal of Pathology|January 30, 2024
Mallory-Denk bodies and hepatocellular senescence: a causal relationship?Helmut Denk, Peter M Abuja, Kurt Zatloukal
EMBO Reports|February 28, 2009
miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasisChristoph A Gebeshuber, Kurt Zatloukal, Javier Martinez
Clinical Chemistry|October 15, 2025
Regulatory Fragmentation in Europe and Its Risks for Patient Access and Safety: Subcontracting Work Flow Steps of In-House Diagnostic ProceduresRaymond Nistor-Gallo, Kurt Zatloukal, Karin Schwenoha
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 11, 2018
Animal models of NAFLD from the pathologist's point of viewHelmut Denk, Peter M Abuja, Kurt Zatloukal
Pageof 21